Paper41249572
DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth.
Williams AF and 13 others. Nat Cell Biol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth. Papers, record 41249572. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41249572
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Interferon Type I | Major topic |
| Humans | |
| Apoptosis | |
| Activating Transcription Factor 3 | |
| Signal Transduction | |
| Cell Line, Tumor | |
| Drug Resistance, Neoplasm | |
| Animals | |
| DNA Damage | |
| Mice | |
| Gene Expression Regulation, Neoplastic | |
| Cell Proliferation | |
| Antineoplastic Agents |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| IRG-19-230-48-IRG | American Cancer Society (American Cancer Society, Inc.) | PubMed | PubMed | ||
| CA212767 | U.S. Department of Health & Human Services | National Institutes of Health (NIH) | R01CA212767 | PubMed and NIH | NIH RePORTER | |
| S10 OD026929 | NIH HHS | United States | S10OD026929 | PubMed and NIH | NIH RePORTER |
| P30 CA023100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH | NIH RePORTER |
| P30 AI036214 | NIAID NIH HHS | United States | P30AI036214 | PubMed and NIH | NIH RePORTER |
| 689282 | Melanoma Research Alliance (MRA) | PubMed | PubMed | ||
| CA067754 | U.S. Department of Health & Human Services | National Institutes of Health (NIH) | T32CA067754 | PubMed and NIH | NIH RePORTER | |
| V2021-035 | V Foundation for Cancer Research (V Foundation) | PubMed | PubMed | ||
| CA009523 | U.S. Department of Health & Human Services | National Institutes of Health (NIH) | T32CA009523 | PubMed and NIH | NIH RePORTER | |
| ME230211 | United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP) | PubMed | PubMed | ||
| T32 CA067754 | NCI NIH HHS | United States | T32CA067754 | PubMed and NIH | NIH RePORTER |
| T32 CA009523 | NCI NIH HHS | United States | T32CA009523 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 40894800 |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19451168 | Fast and accurate short read alignment with Burrows-Wheeler transform. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19451168 | PubMed |
| 2 | 32521256 | Failed Apoptosis Enhances Melanoma Cancer Cell Aggressiveness. | Cell Rep | 2020 | https://conductscience.org/library/papers/32521256 | PubMed |
| 3 | 35353542 | Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35353542 | PubMed |
| 4 | 30341162 | Maftools: efficient and comprehensive analysis of somatic variants in cancer. | Genome Res | 2018 | https://conductscience.org/library/papers/30341162 | PubMed |
| 5 | 26891683 | Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. | Nat Commun | 2016 | https://conductscience.org/library/papers/26891683 | PubMed |
| 6 | 19478064 | Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19478064 | PubMed |
| 7 | 36997393 | Self-inflicted DNA breaks in cell differentiation and cancer. | Trends Cell Biol | 2023 | https://conductscience.org/library/papers/36997393 | PubMed |
| 8 | 26430063 | Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. | Genome Res | 2015 | https://conductscience.org/library/papers/26430063 | PubMed |
| 9 | 33741929 | Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling. | Nat Commun | 2021 | https://conductscience.org/library/papers/33741929 | PubMed |
| 10 | 20639907 | TRAIL treatment provokes mutations in surviving cells. | Oncogene | 2010 | https://conductscience.org/library/papers/20639907 | PubMed |
| 11 | 28981092 | Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28981092 | PubMed |
| 12 | 34320411 | Establishment, maintenance, and recall of inflammatory memory. | Cell Stem Cell | 2021 | https://conductscience.org/library/papers/34320411 | PubMed |
| 13 | 37821702 | Apoptotic stress causes mtDNA release during senescence and drives the SASP. | Nature | 2023 | https://conductscience.org/library/papers/37821702 | PubMed |
| 14 | 30997620 | Proteasome inhibitors trigger mutations via activation of caspases and CAD, but mutagenesis provoked by the HDAC inhibitors vorinostat and romidepsin is caspase/CAD-independent. | Apoptosis | 2019 | https://conductscience.org/library/papers/30997620 | PubMed |
| 15 | 9770511 | Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9770511 | PubMed |
| 16 | 10318789 | Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10318789 | PubMed |
| 17 | 32499442 | MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer. | Science | 2020 | https://conductscience.org/library/papers/32499442 | PubMed |
| 18 | 20371346 | A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. | Cell | 2010 | https://conductscience.org/library/papers/20371346 | PubMed |
| 19 | 36991128 | STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. | Nature | 2023 | https://conductscience.org/library/papers/36991128 | PubMed |
| 20 | 24600036 | PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3. | J Immunol | 2014 | https://conductscience.org/library/papers/24600036 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923094 | Epigenetic adaptations and vulnerabilities in ovarian cancer drug-tolerant persister cells. | NAR Cancer | 2026 | https://conductscience.org/library/papers/42923094 | PubMed |
| 42814839 | Tumor gasdermin E acts as a rheostat to limit apoptotic cell survival and mutagenesis in anticancer immune environments. | Sci Adv | 2026 | https://conductscience.org/library/papers/42814839 | PubMed |
| 42690507 | Evasion of cell death despite mitochondrial outer membrane permeabilization: an oncogenic outcome of apoptosis. | Apoptosis | 2026 | https://conductscience.org/library/papers/42690507 | PubMed |
| 42539880 | Targeting tumor transition windows. | Explor Target Antitumor Ther | 2026 | https://conductscience.org/library/papers/42539880 | PubMed |
| 42360409 | Multidrug resistance in cancer: current understandings and future perspective. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42360409 | PubMed |
| 41761000 | DLX2 marks an immunosuppressive dendritic-cell program that reshapes cytotoxic immunity and marks a tolerogenic microenvironment in lung adenocarcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41761000 | PubMed |
| 41542583 | A kinome inhibitor screen implicates adhesion and growth factor signaling in cellular recovery after caspase activation. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542583 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATF3 | 467 | PubTator's text mining | https://conductscience.org/library/genes/467 | NCBI Gene |
| DFFB | 1677 | PubTator's text mining | https://conductscience.org/library/genes/1677 | NCBI Gene |
| JUNB | 3726 | PubTator's text mining | https://conductscience.org/library/genes/3726 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41249572
GET https://conductscience.org/api/papers/v1/41249572/references?page=2